Florence Launches 8 AI Workflows to Speed Up and Simplify Clinical Trials

Clinical trials have long been slowed by manual processes, scattered data, and inefficient oversight. Florence Healthcare is changing that with the rollout of eight AI-assisted workflows set to launch in October 2025.

These innovations aim to streamline every phase of research, from site selection to monitoring, while boosting compliance and collaboration.

Here are the eight ways Florence’s AI workflows promise to transform clinical research:

1. Smarter Site Identification
   Sponsors can instantly filter sites by geography, therapeutic area, and real-time performance metrics, making it easier to pick the right partners for a successful trial.
2. AI-Powered Feasibility Surveys
   Surveys will be tailored to each study protocol, and sites can lean on AI to provide context-specific responses that highlight their qualifications.
3. Accelerated Contract Negotiations
   AI-assisted tools will simplify back-and-forth contract reviews, reducing delays and ensuring compliance with both sponsor and site requirements.
4. Streamlined Document Exchange
   An automated system will connect directly with site eISFs, allowing documents to be customized by region or network and eliminating the risks of lost files and version confusion.
5. Simplified Study Start-Up
   By removing repetitive manual steps, AI workflows will cut down the time wasted in emails, spreadsheets, and portals, speeding up the critical launch phase of trials.
6. Remote Monitoring With AI Insights
   Sponsors will receive enhanced reports with deeper visibility into site-level progress, reducing the need for expensive and time-consuming physical visits.
7. Interoperability Across Systems
   The workflows come with APIs built for CTMS, eTMF, and identity platforms, ensuring seamless integration instead of relying on fragmented tools.
8. Compliance-Ready Infrastructure
   Florence’s AI tools are built on a validated, GxP-compliant platform with audit traceability and 21 CFR Part 11 support, trusted already by over 37,000 research sites worldwide.

Florence COO Shankar Jagannathan said the focus goes beyond automation: “We’re creating a shared, AI-augmented experience between sponsors and sites to reduce manual work, increase capacity, and minimize risk.”

With this launch, Florence positions itself at the forefront of clinical trial innovation, helping research teams move faster, collaborate better, and stay inspection-ready.